AR111695A2 - Suspensiones acuosas estabilizadas para administración parenteral - Google Patents
Suspensiones acuosas estabilizadas para administración parenteralInfo
- Publication number
- AR111695A2 AR111695A2 ARP180101264A ARP180101264A AR111695A2 AR 111695 A2 AR111695 A2 AR 111695A2 AR P180101264 A ARP180101264 A AR P180101264A AR P180101264 A ARP180101264 A AR P180101264A AR 111695 A2 AR111695 A2 AR 111695A2
- Authority
- AR
- Argentina
- Prior art keywords
- parenteral administration
- methionine
- waterproof
- suspensions stabilized
- stabilized
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Endocrinology (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Oncology (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Una formulación en suspensión acuosa farmacéutica para su administración parenteral que tiene un pH sustancialmente estabilizado, que comprende un compuesto biológicamente activo y una concentración efectiva de control del pH de L-metionina. Uso de L-metionina en la preparación de una formulación en suspensión acuosa farmacéutica que tiene un pH sustancialmente estabilizado, para la administración parenteral de un compuesto biológicamente activo, y de L-metionina y un agente de buffer en concentraciones efectivas como para producir un efecto súper-aditivo de control del pH.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/571,395 US6495534B2 (en) | 2000-05-15 | 2000-05-15 | Stabilized aqueous suspensions for parenteral use |
Publications (1)
Publication Number | Publication Date |
---|---|
AR111695A2 true AR111695A2 (es) | 2019-08-07 |
Family
ID=24283530
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP010102268A AR029924A1 (es) | 2000-05-15 | 2001-05-14 | Suspensiones acuosas estabilizadas para administracion parenteral |
ARP140104760A AR098830A2 (es) | 2000-05-15 | 2014-12-18 | Suspensiones acuosas estabilizadas para administración parenteral |
ARP180101264A AR111695A2 (es) | 2000-05-15 | 2018-05-14 | Suspensiones acuosas estabilizadas para administración parenteral |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP010102268A AR029924A1 (es) | 2000-05-15 | 2001-05-14 | Suspensiones acuosas estabilizadas para administracion parenteral |
ARP140104760A AR098830A2 (es) | 2000-05-15 | 2014-12-18 | Suspensiones acuosas estabilizadas para administración parenteral |
Country Status (30)
Country | Link |
---|---|
US (3) | US6495534B2 (es) |
EP (1) | EP1282402B1 (es) |
JP (1) | JP4205341B2 (es) |
KR (1) | KR100828957B1 (es) |
CN (1) | CN100473376C (es) |
AR (3) | AR029924A1 (es) |
AT (1) | ATE313316T1 (es) |
AU (2) | AU2001267371B2 (es) |
BR (1) | BR0110841A (es) |
CA (1) | CA2409059C (es) |
CZ (1) | CZ303872B6 (es) |
DE (1) | DE60116084T2 (es) |
DK (1) | DK1282402T3 (es) |
EA (1) | EA007682B1 (es) |
EE (1) | EE05376B1 (es) |
ES (1) | ES2254443T3 (es) |
HK (1) | HK1054194B (es) |
HU (1) | HU229800B1 (es) |
IL (2) | IL152537A (es) |
IN (1) | IN224279B (es) |
MX (1) | MXPA02011195A (es) |
NO (1) | NO332215B1 (es) |
NZ (1) | NZ522324A (es) |
PE (1) | PE20011322A1 (es) |
PL (1) | PL203075B1 (es) |
SI (1) | SI1282402T1 (es) |
SK (1) | SK287641B6 (es) |
TW (1) | TWI256310B (es) |
WO (1) | WO2001087266A1 (es) |
ZA (1) | ZA200208738B (es) |
Families Citing this family (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6495534B2 (en) * | 2000-05-15 | 2002-12-17 | Pharmacia & Upjohn Spa | Stabilized aqueous suspensions for parenteral use |
US7482116B2 (en) | 2002-06-07 | 2009-01-27 | Dna Genotek Inc. | Compositions and methods for obtaining nucleic acids from sputum |
WO2004018312A1 (en) | 2002-08-21 | 2004-03-04 | Pharmacia Corporation | Injectable pharmaceutical suspension in a two-chamber vial |
US20050054716A1 (en) * | 2002-11-08 | 2005-03-10 | Gogate Uday Shankar | Pharmaceutical compositions and methods of using taxane derivatives |
KR20060002922A (ko) * | 2003-03-31 | 2006-01-09 | 알자 코포레이션 | 비수성 단일 상 비히클 및 이러한 비히클을 이용한 제형 |
DK1660009T3 (en) | 2003-09-03 | 2015-04-27 | Miscon Trading S A | METHODS OF TREATING ENDOMETRIOSIS |
US20050171167A1 (en) * | 2003-11-04 | 2005-08-04 | Haby Thomas A. | Process and formulation containing epothilones and analogs thereof |
US20050106214A1 (en) * | 2003-11-14 | 2005-05-19 | Guohua Chen | Excipients in drug delivery vehicles |
AU2005285040A1 (en) * | 2004-09-14 | 2006-03-23 | Molecular Therapeutics, Inc. | D-methionine formulation with improved biopharmaceutical properties |
US20060204588A1 (en) * | 2005-03-10 | 2006-09-14 | Elan Pharma International Limited | Formulations of a nanoparticulate finasteride, dutasteride or tamsulosin hydrochloride, and mixtures thereof |
US20070027105A1 (en) | 2005-07-26 | 2007-02-01 | Alza Corporation | Peroxide removal from drug delivery vehicle |
US20070154546A1 (en) * | 2005-12-30 | 2007-07-05 | Zhang Jack Y | Sustained release pharmaceutical compositions |
JP2009526860A (ja) * | 2006-02-15 | 2009-07-23 | ティカ レーケメデル アーベー | 安定したコルチコステロイド混合物 |
TW200806317A (en) * | 2006-03-20 | 2008-02-01 | Wyeth Corp | Methods for reducing protein aggregation |
JP5371180B2 (ja) * | 2006-06-15 | 2013-12-18 | 日立コンシューマエレクトロニクス株式会社 | 投写型映像表示装置 |
JP5624766B2 (ja) * | 2006-09-27 | 2014-11-12 | イーグル・ファーマシューティカルズ・インコーポレーテッド | アルコールを含まないアルガトロバン製剤 |
US7687516B2 (en) * | 2006-09-27 | 2010-03-30 | Eagle Pharmaceuticals, Inc. | Alcohol free formulation of argatroban |
US20100076019A1 (en) * | 2006-10-11 | 2010-03-25 | Eagle Pharmaceuticals, Inc. | Alcohol free formulation of argatroban |
GB0625962D0 (en) * | 2006-12-23 | 2007-02-07 | Renovo Ltd | Medicaments and methods for wound healing |
CA2697160A1 (en) * | 2007-08-21 | 2009-02-26 | Harbor Biosciences, Inc. | Stabilized therapeutic compositions and formulations |
US8287729B2 (en) * | 2008-04-28 | 2012-10-16 | California Polytechnic Corporation | Field water purification system |
GB0813628D0 (en) * | 2008-07-25 | 2008-09-03 | Arrow Int Ltd | Stable coated anti-cancer agent |
UY33103A (es) * | 2009-12-15 | 2011-07-29 | Techsphere S A De C V | Formulacion farmaceutica parenteral en suspension, de liberacion sostenida, en dosis baja y ultra baja, en terapia hormonal en el sindrome climaterico |
RU2014101490A (ru) | 2011-06-19 | 2015-07-27 | Эйбоджен, Инк. | Устройства, растворы и способы для сбора образцов |
ES2885523T3 (es) | 2011-11-23 | 2021-12-14 | Therapeuticsmd Inc | Formulaciones y terapias de reposición hormonal de combinación naturales |
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
UA74095U (ru) * | 2012-07-20 | 2012-10-10 | Николай Иванович Гуменюк | Препарат для лечения туберкулеза |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
WO2015042163A1 (en) * | 2013-09-17 | 2015-03-26 | Terapio Corporation | Methods of preventing or treating mucositis using rlip76 |
CN104706578B (zh) * | 2013-12-14 | 2019-04-23 | 天津金耀集团有限公司 | 一种醋酸甲泼尼龙混悬注射液组合物的制备方法 |
RU2016143081A (ru) | 2014-05-22 | 2018-06-26 | Терапьютиксмд, Инк. | Натуральные комбинированные гормонозаместительные составы и терапии |
US9265396B1 (en) | 2015-03-16 | 2016-02-23 | Irobot Corporation | Autonomous floor cleaning with removable pad |
US9907449B2 (en) | 2015-03-16 | 2018-03-06 | Irobot Corporation | Autonomous floor cleaning with a removable pad |
US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
WO2017149492A1 (en) * | 2016-03-02 | 2017-09-08 | Teva Pharmaceutical Industries Ltd. | Medroxyprogesterone acetate injectable compositions and methods of use |
US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
US9931349B2 (en) | 2016-04-01 | 2018-04-03 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
MX2018013414A (es) * | 2016-05-06 | 2019-06-06 | Eagle Pharmaceuticals Inc | Formulaciones de fulvestrant y metodos para su uso. |
US11590077B2 (en) * | 2016-05-06 | 2023-02-28 | Eagle Pharmaceuticals, Inc. | Fulvestrant formulations and methods of their use |
WO2019049081A1 (en) * | 2017-09-07 | 2019-03-14 | Teva Pharmaceutical Industries Ltd. | INJECTABLE COMPOSITIONS OF MEDROXYPROGESTERONE ACETATE AND METHODS OF USE |
EP3678637A1 (en) * | 2017-09-07 | 2020-07-15 | Teva Pharmaceutical Industries Ltd. | Medroxyprogesterone acetate injectable compositions and methods of use |
JP7220712B2 (ja) * | 2017-11-08 | 2023-02-10 | イーグル ファーマスーティカルズ、インク. | フルベストラント製剤とその使用方法 |
CA3086022A1 (en) | 2018-01-11 | 2019-07-18 | Meritage Pharma, Inc. | Stable corticosteroid compositions |
CA3111901A1 (en) | 2018-09-07 | 2020-03-12 | Prakash SUNDARAMURTHI | Medroxyprogesterone acetate injectable compositions and methods of use |
US10544923B1 (en) | 2018-11-06 | 2020-01-28 | Verifone, Inc. | Devices and methods for optical-based tamper detection using variable light characteristics |
EP3884070A4 (en) | 2018-11-20 | 2022-09-07 | Spectrum Solutions, LLC | SAMPLE COLLECTION SYSTEM INCLUDING SEALING CAP AND VALVE |
IT201900002857A1 (it) * | 2019-02-27 | 2020-08-27 | Ntc S R L | Procedimento di riempimento di contenitori con una polvere |
US11701094B2 (en) | 2019-06-20 | 2023-07-18 | Spectrum Solutions L.L.C. | Sample collection system including valve and plug assemblies |
BR112022013784A2 (pt) | 2020-01-13 | 2022-10-11 | Durect Corp | Sistemas de distribuição de fármacos de liberação prolongada com impurezas reduzidas e métodos relacionados |
US11633405B2 (en) | 2020-02-07 | 2023-04-25 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical formulations |
WO2022245939A1 (en) * | 2021-05-19 | 2022-11-24 | Acies Medical Llc | Point-of-use calibration system for iron ion detection system |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2861920A (en) * | 1954-05-04 | 1958-11-25 | Upjohn Co | Therapeutic suspensions of steroids containing pvp and/or pva |
JPS5831210B2 (ja) * | 1973-04-09 | 1983-07-05 | 武田薬品工業株式会社 | アンテイナスイセイケンダクエキノセイゾウホウ |
US4038389A (en) * | 1975-05-07 | 1977-07-26 | The Upjohn Company | Medroxyprogesterone acetate compositions |
US4154820A (en) * | 1976-02-23 | 1979-05-15 | Akzona Incorporated | Compositions containing alkali metal sulfate salts of conjugated estrogens and antioxidants as stabilizers |
JP2577744B2 (ja) | 1986-07-18 | 1997-02-05 | 中外製薬株式会社 | 安定な顆粒球コロニ−刺激因子含有製剤 |
ES2062310T3 (es) | 1989-12-06 | 1994-12-16 | Akzo Nv | Un procedimiento para fabricar un preparado farmaceutico acuoso estabilizado. |
US5208261A (en) * | 1989-12-06 | 1993-05-04 | Akzo N.V. | Stabilized solutions of psychotropic agents |
JPH0597671A (ja) | 1991-10-04 | 1993-04-20 | Sumitomo Pharmaceut Co Ltd | 注射用凍結乾燥製剤 |
CA2120197A1 (en) | 1993-04-02 | 1994-10-03 | Kenji Endo | Stable aqueous dispersions containing liposomes |
JP3862295B2 (ja) * | 1993-09-30 | 2006-12-27 | 独立行政法人理化学研究所 | 抗肥満剤 |
US5540930A (en) * | 1993-10-25 | 1996-07-30 | Pharmos Corporation | Suspension of loteprednol etabonate for ear, eye, or nose treatment |
JP3543144B2 (ja) | 1995-03-11 | 2004-07-14 | 国際試薬株式会社 | 臨床検査用製剤 |
US5780431A (en) | 1996-09-20 | 1998-07-14 | Neurobiological Technologies, Inc. | Pharmaceutical formulations of corticotropin releasing factor having improved stability in liquid form |
CN1142940C (zh) | 1996-10-04 | 2004-03-24 | 安姆根有限公司 | 含有mpl配体的药物组合物 |
US5773432A (en) * | 1996-10-30 | 1998-06-30 | Schering Aktiengesellschaft | Method for lowering plasma levels of lipoprotein(a) |
US5880116A (en) * | 1996-12-13 | 1999-03-09 | Neurocal International | Use of celastrol to treat alzheimer's disease |
JP3748970B2 (ja) | 1997-01-31 | 2006-02-22 | 電気化学工業株式会社 | ヒアルロン酸ナトリウム含有水溶液 |
KR100508227B1 (ko) | 1997-03-14 | 2006-03-23 | 센주 세이야꾸 가부시키가이샤 | 로테프레드놀에타보네이트수성현탁액 |
CA2304808C (en) | 1997-09-23 | 2011-03-22 | Michael Tschope | Liquid interferon-.beta. formulations |
US5968918A (en) * | 1997-10-17 | 1999-10-19 | Kanda; Iwao | Method for the prevention of coronary artery spasm |
US5972921A (en) * | 1997-12-12 | 1999-10-26 | Hormos Medical Oy Ltd. | Use of an aromatase inhibitor in the treatment of decreased androgen to estrogen ratio and detrusor urethral sphincter dyssynergia in men |
PT1067934E (pt) | 1998-04-02 | 2004-03-31 | Akzo Nobel Nv | Solucao anti-depressiva liquida oral |
IL149008A0 (en) | 1999-10-04 | 2002-11-10 | Chiron Corp | Stabilized liquid polypeptide-containing pharmaceutical compositions |
US6495534B2 (en) * | 2000-05-15 | 2002-12-17 | Pharmacia & Upjohn Spa | Stabilized aqueous suspensions for parenteral use |
-
2000
- 2000-05-15 US US09/571,395 patent/US6495534B2/en not_active Expired - Lifetime
-
2001
- 2001-04-25 IL IL152537A patent/IL152537A/en active IP Right Grant
- 2001-04-25 JP JP2001583735A patent/JP4205341B2/ja not_active Expired - Lifetime
- 2001-04-25 IN IN1996CH2002 patent/IN224279B/en unknown
- 2001-04-25 EA EA200201208A patent/EA007682B1/ru not_active IP Right Cessation
- 2001-04-25 CZ CZ20023750A patent/CZ303872B6/cs not_active IP Right Cessation
- 2001-04-25 PL PL365793A patent/PL203075B1/pl unknown
- 2001-04-25 BR BR0110841-7A patent/BR0110841A/pt not_active Application Discontinuation
- 2001-04-25 AU AU2001267371A patent/AU2001267371B2/en not_active Expired
- 2001-04-25 EE EEP200200631A patent/EE05376B1/xx unknown
- 2001-04-25 AU AU6737101A patent/AU6737101A/xx active Pending
- 2001-04-25 CN CNB018095895A patent/CN100473376C/zh not_active Expired - Lifetime
- 2001-04-25 KR KR1020027015431A patent/KR100828957B1/ko active IP Right Grant
- 2001-04-25 SK SK1598-2002A patent/SK287641B6/sk not_active IP Right Cessation
- 2001-04-25 NZ NZ522324A patent/NZ522324A/en not_active IP Right Cessation
- 2001-04-25 EP EP01945040A patent/EP1282402B1/en not_active Expired - Lifetime
- 2001-04-25 CA CA002409059A patent/CA2409059C/en not_active Expired - Lifetime
- 2001-04-25 AT AT01945040T patent/ATE313316T1/de active
- 2001-04-25 WO PCT/EP2001/004643 patent/WO2001087266A1/en active IP Right Grant
- 2001-04-25 MX MXPA02011195A patent/MXPA02011195A/es active IP Right Grant
- 2001-04-25 HU HU0302021A patent/HU229800B1/hu unknown
- 2001-04-25 SI SI200130485T patent/SI1282402T1/sl unknown
- 2001-04-25 ES ES01945040T patent/ES2254443T3/es not_active Expired - Lifetime
- 2001-04-25 DE DE60116084T patent/DE60116084T2/de not_active Expired - Lifetime
- 2001-04-25 DK DK01945040T patent/DK1282402T3/da active
- 2001-05-09 TW TW090111029A patent/TWI256310B/zh not_active IP Right Cessation
- 2001-05-14 AR ARP010102268A patent/AR029924A1/es not_active Application Discontinuation
- 2001-05-14 PE PE2001000431A patent/PE20011322A1/es active IP Right Grant
-
2002
- 2002-08-21 US US10/225,320 patent/US20030114430A1/en not_active Abandoned
- 2002-10-10 US US10/267,690 patent/US20030130245A1/en not_active Abandoned
- 2002-10-29 ZA ZA200208738A patent/ZA200208738B/xx unknown
- 2002-11-13 NO NO20025431A patent/NO332215B1/no not_active IP Right Cessation
-
2003
- 2003-09-11 HK HK03106493.6A patent/HK1054194B/zh not_active IP Right Cessation
-
2004
- 2004-12-21 IL IL16588804A patent/IL165888A0/xx unknown
-
2014
- 2014-12-18 AR ARP140104760A patent/AR098830A2/es unknown
-
2018
- 2018-05-14 AR ARP180101264A patent/AR111695A2/es unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR111695A2 (es) | Suspensiones acuosas estabilizadas para administración parenteral | |
CO5700797A2 (es) | Composicion de farmaco conjugado | |
AR052545A1 (es) | Suspension no acuosa inyectable | |
ES2531083T3 (es) | Formulaciones estables de polipéptidos y usos de las mismas | |
AR067011A1 (es) | Formulaciones de anticuerpos | |
AR078161A1 (es) | Formulaciones farmaceuticas muy concentradas de un anticuerpo anti cd20. uso de la formulacion. metodo de tratamiento. | |
UA99815C2 (ru) | Лиофилизированная композиция терапевтического пептидного антитела | |
AR047949A1 (es) | Preparacion farmaceutica que comprende un anticuerpo contra el receptor de factor de crecimiento endotelial | |
AR049063A1 (es) | Composiciones farmaceuticas inyectables de posaconazol con particulas estabilizadas | |
CU23367A3 (es) | Formulación de moxifloxacino con sal común | |
BRPI0413957A (pt) | processo para preparar diterpenos solúveis em água, solução aquosa e suas aplicações | |
ES2720954T3 (es) | Formulaciones estabilizadas de estatina | |
AR071568A1 (es) | Composicion de suspension pesticida acuosa | |
CO5180582A1 (es) | Soluciones farmaceuticas de levosimendan | |
AR034370A1 (es) | Una preparacion farmaceutica acuosa de cilostazol para uso parenteral | |
BRPI0517245A (pt) | suspensão farmacêutica e de acetaminofeno isentas de corantes | |
ATE552825T1 (de) | Flüssige orale zusammensetzungen | |
ATE367165T1 (de) | Xanthangummi enthaltende reepithelialisierende pharmazeutische zubereitungen | |
EA200300406A1 (ru) | Фармацевтическая композиция дронедарона для парентерального введения | |
MA27850A1 (fr) | Preparations pharmaceutiques contenant de l'amoxicilline et du clavulanate | |
AR032326A1 (es) | Suspension esteroidal estabilizada | |
CL2004000496A1 (es) | Composicion farmaceutica liquida de administracion oral que comprende agua, acido metil-2-(2'-cloro-6'-fluoroanilino) fenilacetico, y un agente de suspension, con un ph entre 4,5 y 5,5; metodo de preparacion; uso para tratar un trastorno dependiente | |
AR034554A1 (es) | Un metodo para mejorar la distribucion de un ingrediente activo en un licor de curtido, una tableta o bloque para ser usado en dicho metodo, y el uso de dicha tableta o bloque en el curtido de cuero | |
DE60115667D1 (de) | Säureempfindliche verbindungen, deren herstellung und verwendungen | |
AR051412A1 (es) | Suspensiones farmaceuticas exentas de colorantes y metodods relacionados |